The safety of isotretinoin in patients with lupus nephritis: a comprehensive review

References

• Florez Boettgwer R, Fukushima LH. Common skin disorders. In: Helms RA, Quan DJ, eds. Textbook of therapeutics drug and disease management. Philadelphia: Lippincott Williams & Wilkins; 2006:204–216.
   Google Scholar
• Ozpolat B, Lopez-Berestein G, Mehta K. All-trans-retinoic acid and treatment of acute promyelocytic leukemia. In: Loessing IT, eds. Vitamin A: new research. New York: Nova Science Publishers; 2007:1–23.
   Google Scholar
• Karadag AS, Kalkan G, Lin YT, Chen WC. Update of oral isotretinoin in acne treatment. In: Khanna N, Kubba R, eds. World clinic dermatology: acne. New Delhi: JP Medical Ltd; 2014:169–200.
   Google Scholar
• Davidovici BB, Tüzün Y, Wolf R. Retinoid receptors. Dermatol Clin 2007;25:525–530.
   PubMed Web of Science ®Google Scholar
• Muindi JR, Roth MD, Wise RA, et al. Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients. J Clin Pharmacol 2008;48:96–107.
   PubMed Web of Science ®Google Scholar
• Wiegand UW, Chou RC. Pharmacokinetics of oral isotretinoin. J Am Acad Dermatol 1998;39:S8–S12.
   PubMed Web of Science ®Google Scholar
• Armaly Z, Haj S, Bowirrat A, et al. Acute kidney injury following isotretinoin treatment. Am J Case Rep 2013;14:554–556.
   PubMedGoogle Scholar
• Pavese P, Kuentz F, Belleville C, et al. Renal impairment induced by isotretinoin. Nephrol Dial Transplant 1997;12:1299.
   PubMed Web of Science ®Google Scholar
• Van Oers JA, de Leeuw J, van Bommel EF. Nephrotic syndrome associated with isotretinoin. Nephrol Dial Transplant 2000;15:923–924.
   PubMed Web of Science ®Google Scholar
• Sethna CB, Reddy K, Fein-Levy C, Trachtman H. Nephrotic-range proteinuria in a child with retinoic acid syndrome. Pediatr Nephrol 2012;27:485–488.
   PubMed Web of Science ®Google Scholar
• Yarali N, Tavil B, Kara A, et al. Acute renal failure during ATRA treatment. Pediatr Hematol Oncol 2008;25:115–118.
   PubMed Web of Science ®Google Scholar
• Moresco G, Martinello F, Souza LC. Acute renal failure in patient treated with ATRA and amphotericin B: case report. J Bras Nefrol 2011;33:276–281.
   PubMedGoogle Scholar
• Flombaum CD, Isaacs M, Reich L, et al. Acute renal failure associated with the retinoic acid syndrome in acute promyelocytic leukemia. Am J Kidney Dis 1996;27:134–137.
   PubMed Web of Science ®Google Scholar
• King C, Sherner J. Retinoic acid syndrome: a case report and review. Internet J Oncol 2004;2.
   Google Scholar
• Sastre A, Gago E, Baños M, Gómez E. Acute renal failure in the transretinoic syndrome. Nefrologia 2007;27:184–190.
   PubMed Web of Science ®Google Scholar
• Hammoud D, El Haddad B, Abdallah J. Hypercalcaemia secondary to hypervitaminosis a in a patient with chronic renal failure. West Indian Med J 2014;63:105–108.
   PubMed Web of Science ®Google Scholar
• Gavrilov V, Gorodischer R. Renal handling of retinol in kidney disease. In: Loessing IT, ed. Vitamin A: new research. New York: Nova Science Publishers; 2007:125–137
   Google Scholar
• Manickavasagar B, McArdle AJ, Yadav P, et al. Hypervitaminosis A is prevalent in children with CKD and contributes to hypercalcemia. Pediatr Nephrol 2015;30:317–325.
   PubMed Web of Science ®Google Scholar
• Nickle SB, Peterson N, Peterson M. Updated Physician's guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol 2014;7:22–34.
   PubMedGoogle Scholar
• Green SG, Piette WW. Successful treatment of hypertrophic lupus erythematosus with isotretinoin. J Am Acad Dermatol 1987;17:364–368.
   PubMed Web of Science ®Google Scholar
• Richert B, André J, Bourguignon R, de la Brassinne M. Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties. J Eur Acad Dermatol Venereol 2004;18:728–730.
   PubMed Web of Science ®Google Scholar
• Bertsias G, Cervera R, Boumpas DT. Systemic lupus erythematosus: pathogenesis and clinical features. In: Bijlsma JWJ, ed. EULAR textbook on rheumatic diseases. London: BMJ Publishing Group Ltd; 2012:476–505
   Google Scholar
• Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 2011;13:1–9.
   Web of Science ®Google Scholar
• Anders HJ, Fogo AB. Immunopathology of lupus nephritis. Semin Immunopathol 2014;36:443–459.
   PubMed Web of Science ®Google Scholar
• Liu Y, Anders HJ. Lupus nephritis: from pathogenesis to targets for biologic treatment. Nephron Clin Pract 2014;128:224–231.
   PubMedGoogle Scholar
• Rovin B, Samir V, Parikh S. Lupus nephritis: the evolving role of novel therapeutics. Am J Kidney Dis 2014;63:677–690.
   PubMed Web of Science ®Google Scholar
• Liao X, Ren J, Wei CH, et al. Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model. PLoS One 2015;10:e0118176. doi:http://dx.doi.org/10.1371/journal.pone.0118176.
   PubMed Web of Science ®Google Scholar
• Pérez de Lema G, Lucio-Cazaña FJ, Molina A, et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int 2004;66:1018–1028.
   PubMed Web of Science ®Google Scholar
• Nozaki Y, Yamagata T, Yoo BS, et al. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice. Clin Exp Immunol 2005;139:74–83.
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Yoo BS, Nozaki Y, et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J Immunol 2003;170:5793–5798.
   PubMed Web of Science ®Google Scholar
• Stoll ML, Gavalchin J. Systemic lupus erythematosus-messages from experimental models. Rheumatology (Oxford) 2000;39:18–27.
   PubMed Web of Science ®Google Scholar
• Perry D, Sang A, Yin Y, et al. Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011;2011:271694. doi:http://dx.doi.org/10.1155/2011/271694.
   PubMedGoogle Scholar
• Gigante A, Gasperini ML, Afeltra A, et al. Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci 2011;15:15–24.
   PubMed Web of Science ®Google Scholar
• Schwarting A, Wada T, Kinoshita K, et al. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 1998;161:494–503.
   PubMed Web of Science ®Google Scholar
• Horwitz DA. The clinical significance of decreased T cell interleukin-2 production in systemic lupus erythematosus: connecting historical dots. Arthritis Rheum 2010;62:2185–2187.
   PubMed Web of Science ®Google Scholar
• Kitamura M, Sütö TS. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 1997;12:669–679.
   PubMed Web of Science ®Google Scholar
• Hammad AM, Youssef HM, El-Arman MM. Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis. Lupus 2006;15:608–612.
   PubMed Web of Science ®Google Scholar
• Morath C, Dechow C, Lehrke I, et al. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis. J Am Soc Nephrol 2001;12:2300–2309.
   PubMed Web of Science ®Google Scholar
• Schaier M, Lehrke I, Schade K, et al. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int 2001;60:2222–2234.
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Kishimoto K, Shimazu H, et al. Successful treatment with retinoids in patients with lupus nephritis. Am J Kidney Dis 2010;55:344–347.
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Funauchi M. Therapeutic effect of retinoic acid in lupus nephritis. Nihon Rinsho Meneki Gakkai Kaishi 2012;35:1–7.
   PubMedGoogle Scholar
• Wagner J, Dechow C, Morath C, et al. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol 2000;11:1479–1487.
   PubMed Web of Science ®Google Scholar
• Trivedi S, Zeier M, Reiser J. Role of podocytes in lupus nephritis. Nephrol Dial Transplant 2009;24:3607–3612.
   PubMed Web of Science ®Google Scholar
• Bollain-y-Goytia JJ, González-Castañeda M, Torres-del-Muro F, et al. Increased excretion of urinary podocytes in lupus nephritis. Indian J Nephrol 2011;21:166–171.
   PubMedGoogle Scholar
• Greka A, Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol 2012;74:299–323.
   PubMed Web of Science ®Google Scholar
• Neal CR. Podocytes … What's under yours? (Podocytes and foot processes and how they change in nephropathy). Front Endocrinol (Lausanne) 2015;6:9. doi:10.3389/fendo.2015.00009a.
   PubMed Web of Science ®Google Scholar
• Lehtonen S. Connecting the interpodocyte slit diaphragm and actin dynamics: emerging role for the nephrin signaling complex. Kidney Int 2008;73:903–905.
   PubMed Web of Science ®Google Scholar
• Kriz W, Hähnel B, Hosser H, et al. Structural analysis of how podocytes detach from the glomerular basement membrane under hypertrophic stress. Front Endocrinol (Lausanne) 2014;5:207. doi:doi: 10.3389/fendo.2014.00207.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu F, Song D, et al. Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre. Rheumatology (Oxford) 2014;53:1235–1244.
   PubMed Web of Science ®Google Scholar
• Moustafa FE, Soliman NA, Bakr AM, El Shwaf IM. Assessment of detached podocytes in the Bowman's space as a marker of disease activity in lupus nephritis. Lupus 2014;23:146–150.
   PubMed Web of Science ®Google Scholar
• Peired A, Lazzeri E, Lasagni L, Romagnani P. Glomerular regeneration: when can the kidney regenerate from injury and what turns failure into success? Nephron Exp Nephrol 2014. doi: 10.1159/000360669.
   PubMedGoogle Scholar
• Lasagni L, Angelotti ML, Ronconi E, et al. Podocyte regeneration driven by renal progenitors determines glomerular disease remission and can be pharmacologically enhanced. Stem Cell Reports 2015;5:248–263.
   PubMed Web of Science ®Google Scholar
• Zhang J, Pippin JW, Vaughan MR, et al. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease. Nephron Exp Nephrol 2012;121:e23–e37. doi: 10.1159/000342808.
   PubMedGoogle Scholar
• Lazzeri E, Peired AJ, Lasagni L, Romagnani P. Retinoids and glomerular regeneration. Semin Nephrol 2014;34:429–436.
   PubMed Web of Science ®Google Scholar
• Peired A, Angelotti ML, Ronconi E, et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol 2013;24:1756–1768.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Ito T, Imai E, et al. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol 2003;14:981–991.
   PubMed Web of Science ®Google Scholar
• Carney EF. Glomerular disease: albuminuria inhibits podocyte regeneration. Nat Rev Nephrol 2013;9:554. doi: 10.1038/nrneph.2013.159.
   PubMedGoogle Scholar
• Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, et al. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol 2003;139:823–831.
   PubMed Web of Science ®Google Scholar
• Kawachi H, Miyauchi N, Suzuki K, et al. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton) 2006;11:274–281.
   PubMed Web of Science ®Google Scholar
• Morath C, Ratzlaff K, Dechow C, et al. Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. J Mol Med (Berl) 2009;87:53–64.
   PubMed Web of Science ®Google Scholar
• Zhou TB, Wu WF, Qin YH, Yin SS. Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats. J Renin Angiotensin Aldosterone Syst 2013;14:299–307.
   PubMed Web of Science ®Google Scholar
• Schaier M, Liebler S, Schade K, et al. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med (Berl) 2004;82:116–125.
   PubMed Web of Science ®Google Scholar
• Lehrke I, Schaier M, Schade K, et al. Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. Am J Physiol Renal Physiol 2002;282:F741–F751.
   PubMed Web of Science ®Google Scholar
• Maguire JJ, Davenport AP. Endothelin receptors and their antagonists. Semin Nephrol 2015;35:125–136.
   PubMed Web of Science ®Google Scholar
• Miyabe Y, Miyabe C, Nanki T. Could retinoids be a potential treatment for rheumatic diseases? Rheumatol Int 2015;35:35–41.
   PubMed Web of Science ®Google Scholar